Stice L L, Vaziri C, Faller D V
Cancer Research Center, Boston University School of Medicine, Boston, MA, USA.
Front Biosci. 1999 Jan 15;4:D72-86. doi: 10.2741/stice.
Elucidating the molecular mechanisms regulating transduction of growth control signals and the discovery of the subversion of these pathways by oncogenes has proven critical in unraveling the biochemical factors leading to cellular transformation. One such line of investigation has been study of the effects of transforming p21Ras on platelet-derived growth factor type-beta receptor (PDGF-betaR) signaling. Platelet-derived growth factor is an important extracellular factor regulating the G0-S phase transition of mesenchymal cells. Expression of activated, oncogenic Kirsten- or Harvey-p21Ras in cells influences PDGF-betaR signaling at multiple levels. At least two separate mechanisms account for defective PDGF-betaR signaling in activated p21Ras-expressing cells: (i) transcriptional down-regulation of PDGF-betaR expression, and (ii) inhibition of ligand-induced PDGF-betaR phosphorylation by a factor which is present in the cellular membrane fraction of fibroblasts expressing activated p21Ras. The state of growth arrest in G0 is associated with increased expression of the PDGF-betaR, and oncogene-transformed cell lines, which fail to undergo growth-arrest following prolonged serum-deprivation, express constitutively low levels of the PDGF-betaR mRNA, and possess greatly reduced numbers of PDGF-BB-binding sites. This repression of PDGF-betaR expression by p21Ras is, at least in large part, transcriptional. The membrane-associated factor induced by oncogenic p21Ras provides a connection between cell morphology and cytoskeletal elements and control of ligand-dependent PDGF-betaR autophosphorylation. Reversion of the transformed phenotype results in the recovery of PDGF-betaR kinase activity. Conversely, disruption of the actin cytoskeleton of untransformed fibroblasts leads to the loss of PDGF-betaR function. These studies define two potential mechanisms for feedback control of PDGF-betaR function by downstream elements in the PDGF signaling pathway. In addition, the connection between cell morphology and the function of the PDGF-betaR established by these studies provides a new mechanistic link between the organization of the cytoskeleton, the Ras-related small G proteins, and the activity of membrane-bound receptor tyrosine kinases.
阐明调节生长控制信号转导的分子机制以及癌基因对这些信号通路的颠覆,已被证明对于揭示导致细胞转化的生化因素至关重要。其中一项研究方向是研究转化型p21Ras对血小板衍生生长因子β型受体(PDGF-βR)信号传导的影响。血小板衍生生长因子是调节间充质细胞G0-S期转变的重要细胞外因子。在细胞中表达活化的致癌性 Kirsten-或 Harvey-p21Ras会在多个水平上影响PDGF-βR信号传导。至少有两种不同的机制可解释在表达活化p21Ras的细胞中PDGF-βR信号传导缺陷:(i)PDGF-βR表达的转录下调,以及(ii)表达活化p21Ras的成纤维细胞细胞膜组分中存在的一种因子对配体诱导的PDGF-βR磷酸化的抑制。G0期的生长停滞状态与PDGF-βR表达增加相关,而癌基因转化的细胞系在长期血清剥夺后未能经历生长停滞,其PDGF-βR mRNA组成型表达水平较低,且PDGF-BB结合位点数量大幅减少。p21Ras对PDGF-βR表达的这种抑制至少在很大程度上是转录性的。致癌性p21Ras诱导的膜相关因子在细胞形态与细胞骨架元件之间建立了联系,并控制配体依赖性PDGF-βR的自磷酸化。转化表型的逆转导致PDGF-βR激酶活性的恢复。相反,未转化的成纤维细胞的肌动蛋白细胞骨架的破坏会导致PDGF-βR功能丧失。这些研究确定了PDGF信号通路中下游元件对PDGF-βR功能进行反馈控制的两种潜在机制。此外,这些研究建立的细胞形态与PDGF-βR功能之间的联系,在细胞骨架组织、Ras相关小G蛋白和膜结合受体酪氨酸激酶活性之间提供了一个新的机制联系。